|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
10,003 |
$1,507,752.19 |
7.37% |
| Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
62,454 |
$1,491,401.52 |
7.29% |
| AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
7,897 |
$1,464,814.53 |
7.16% |
| Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
17,893 |
$1,418,735.97 |
6.93% |
| Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
27,686 |
$1,296,812.24 |
6.34% |
| Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
89,418 |
$784,195.86 |
3.83% |
| Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
7,220 |
$779,760.00 |
3.81% |
| Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
2,679 |
$775,918.77 |
3.79% |
| Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
4,935 |
$765,221.10 |
3.74% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
2,579 |
$752,345.88 |
3.68% |
| Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
5,874 |
$743,295.96 |
3.63% |
| Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
896 |
$703,386.88 |
3.44% |
| Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
5,750 |
$622,380.00 |
3.04% |
| Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
1,181 |
$606,537.98 |
2.96% |
| Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
11,273 |
$459,262.02 |
2.24% |
| Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
33,755 |
$449,954.15 |
2.20% |
| Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
2,864 |
$416,110.56 |
2.03% |
| Organon & Co. |
OGN |
68622V106 |
Pharmaceuticals |
40,033 |
$395,526.04 |
1.93% |
| Illumina, Inc. |
ILMN |
452327109 |
Biotechnology |
4,318 |
$389,742.68 |
1.90% |
| Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
1,253 |
$379,270.57 |
1.85% |
| Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
2,610 |
$332,279.10 |
1.62% |
| Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
5,241 |
$278,559.15 |
1.36% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
4,058 |
$224,163.92 |
1.10% |
| Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
7,365 |
$216,015.45 |
1.06% |
| Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
7,499 |
$197,373.68 |
0.96% |
| Amneal Pharmaceuticals, Inc. |
AMRX |
03168L105 |
Pharmaceuticals |
21,952 |
$174,298.88 |
0.85% |
| Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
2,021 |
$169,036.44 |
0.83% |
| Catalyst Pharmaceuticals, Inc. |
CPRX |
14888U101 |
Biotechnology |
6,766 |
$154,332.46 |
0.75% |
| Blueprint Medicines Corporation |
BPMC |
09627Y109 |
Pharmaceuticals |
1,178 |
$150,925.36 |
0.74% |
| Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
879 |
$145,386.60 |
0.71% |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Biotechnology |
461 |
$143,979.52 |
0.70% |
| Insmed Incorporated |
INSM |
457669307 |
Biotechnology |
1,395 |
$138,746.70 |
0.68% |
| Guardant Health, Inc. |
GH |
40131M109 |
Biotechnology |
2,674 |
$135,224.18 |
0.66% |
| ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
5,805 |
$133,224.75 |
0.65% |
| Corcept Therapeutics Inc. |
CORT |
218352102 |
Pharmaceuticals |
1,878 |
$133,788.72 |
0.65% |
| TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
3,781 |
$132,958.87 |
0.65% |
| Akero Therapeutics, Inc. |
AKRO |
00973Y108 |
Biotechnology |
2,316 |
$127,148.40 |
0.62% |
| ADMA Biologics, Inc. |
ADMA |
000899104 |
Biotechnology |
6,942 |
$125,858.46 |
0.61% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
Biotechnology |
2,400 |
$125,616.00 |
0.61% |
| Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
1,548 |
$105,681.96 |
0.52% |
| Scholar Rock Holding Corporation |
SRRK |
80706P103 |
Biotechnology |
2,931 |
$106,453.92 |
0.52% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
237 |
$106,270.80 |
0.52% |
| PTC Therapeutics, Inc. |
PTCT |
69366J200 |
Biotechnology |
2,059 |
$103,835.37 |
0.51% |
| Madrigal Pharmaceuticals, Inc. |
MDGL |
558868105 |
Biotechnology |
333 |
$94,145.76 |
0.46% |
| Axsome Therapeutics, Inc. |
AXSM |
05464T104 |
Biotechnology |
892 |
$91,777.88 |
0.45% |
| SpringWorks Therapeutics, Inc. |
SWTX |
85205L107 |
Biotechnology |
1,970 |
$92,156.60 |
0.45% |
| Vericel Corporation |
VCEL |
92346J108 |
Biotechnology |
2,218 |
$92,668.04 |
0.45% |
| Veracyte, Inc. |
VCYT |
92337F107 |
Biotechnology |
3,273 |
$87,781.86 |
0.43% |
| Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
635 |
$83,877.15 |
0.41% |
| US Dollar |
$USD |
|
Other |
42,167 |
$42,166.85 |
0.21% |
| Sarepta Therapeutics, Inc. |
SRPT |
803607100 |
Biotechnology |
1,066 |
$22,140.82 |
0.11% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|